Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.023 | 0.7 |
mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.7 |
mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.027 | 0.7 |
mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.7 |